Assessment of Volatile Organic Compounds (VOC) for the Diagnosis of Invasive Aspergillosis (IA) in Lung Transplant Recipients
NCT06344117 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 45
Last updated 2024-04-03
Summary
Prospective observational pilot study to evaluate the utility of breath VOCs to detect invasive aspergillosis in lung transplant recipients that are suspected of invasive fungal disease (IFD).
Conditions
- Invasive Aspergillosis
Sponsors & Collaborators
-
Owlstone Ltd
lead INDUSTRY
Principal Investigators
-
Shahid Husain, MD,MS · University Health Network, Toronto
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-12
- Primary Completion
- 2025-07-31
- Completion
- 2025-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Efficacy of Intrabronchial Voriconazole Instillation for Inoperable Pulmonary Aspergilloma
NCT03799809 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Isavuconazole in Critically Ill Patients: Efficacy and Safety
NCT07080359 ·Status: NOT_YET_RECRUITING
-
Voriconazole Prophylaxis Against Aspergillosis in Lung Transplant Recipients
NCT00177827 ·Status: COMPLETED
-
Itraconazole Therapy In Bronchiectasis With Airway Mold
NCT07283497 ·Status: RECRUITING ·Phase: PHASE4
-
Exhaled Breath Analysis in the Early Detection of Aspergillosis
NCT02106117 ·Status: COMPLETED
-
Voriconazole as Prophylactic Therapy in Lung Transplant Recipients
NCT00455364 ·Status: TERMINATED ·Phase: PHASE4
-
Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients
NCT06654076 ·Status: COMPLETED
-
Systemic Fungal Infections in ICU Patients
NCT03292224 ·Status: UNKNOWN
-
Value of Amphotericin B Inhalation for Prophylaxis of Invasive Pulmonary Aspergillosis After Renal Transplantation
NCT00986713 ·Status: UNKNOWN ·Phase: PHASE4
-
CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients
NCT02100761 ·Status: UNKNOWN
-
Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections
NCT06387667 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Compare Oral Itraconazole and Standard Care Versus Standard Care Alone in Patients With Non-cystic Fibrosis Related Bronchiectasis With Chronic Aspergillus Infection in Reducing Bronchiectasis Exacerbations
NCT06160713 ·Status: RECRUITING ·Phase: PHASE3
-
A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis
NCT04824417 ·Status: COMPLETED ·Phase: PHASE3
-
Early Diagnosis of Invasive Lung Aspergillosis
NCT05860387 ·Status: RECRUITING
-
Siderophore-labelled Positron Emission Tomography for Correlating Invasive Fungal InfeCtions
NCT06105411 ·Status: RECRUITING
-
Voriconazole for IPA in Chinese Patients With COPD
NCT02234739 ·Status: UNKNOWN ·Phase: PHASE4
-
ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study
NCT06028451 ·Status: RECRUITING
-
Bioavailability of Voriconazole
NCT02110316 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluate Safety and Efficacy of the Coadministration of Ibrexafungerp With Voriconazole in Patients With Invasive Pulmonary Aspergillosis
NCT03672292 ·Status: TERMINATED ·Phase: PHASE2
-
Prevalence of Influenza RelAted Invasive Aspergillosis
NCT04172610 ·Status: COMPLETED
-
Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis
NCT00001646 ·Status: COMPLETED ·Phase: PHASE3
-
Amphotericin-B and Voriconazole for Pulmonary Blastomycosis
NCT02283905 ·Status: TERMINATED ·Phase: PHASE4
-
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
NCT03827694 ·Status: RECRUITING
-
Efficacy Of Itraconazole In Chronic Cavitary Pulmonary Aspergillosis
NCT01259336 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Pulmonary Cryptococcosis in China
NCT02503449 ·Status: UNKNOWN